Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are over 18 years old
- People who are able to give written consent to take part in the study
- Women who are either past menopause or, if they could become pregnant, using a suitable form of contraception
- Men who are using a suitable form of contraception for the duration of the study
- People who have a kidney mass that imaging scans suggest, or a biopsy has confirmed, may be either non-cancerous or cancerous
- People who are able to attend at least one study visit
Who may not be able to join:
- People who are unable to have an MRI scan, or for whom an MRI scan is not safe
- Women who are pregnant or currently breastfeeding
- People using an intrauterine contraceptive device (IUD/coil) that has not been confirmed as safe for use in a 3 Tesla MRI scanner (the trial site will need to confirm this)
- People with serious heart, lung, or neurological conditions, as assessed by the trial investigators
- People with certain abnormal blood or laboratory test results that could affect the study findings
- People with any other significant medical or mental health history that the trial investigators consider would make participation unsuitable
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ferdia A Gallagher, MD PhD, Principal Investigator
Phone: +44 1223 767062
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
LAC/PYR ratio; Total Sodium Concentration; Technical development of DMI in the abdomen
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.